Locations
Paris, France · Suresnes, France · Paris, France
industry
Biotechnology
Size
11-50 employees
Stage
Series A
founded in
2021
We founded Phagos out of a common ideal: to use entrepreneurship as a force for positive change. Antibiotic resistance is an urgent and unaddressed global challenge that was declared a top 10 threat to humanity by the World Health Organization. Experts project that this 'silent pandemic' could kill 10 million people per year by 2050. At Phagos, we're dedicated to finding a solution. Our approach is evolutionary—we harness the natural predator of bacteria, the bacteriophage, to cure these life-threatening infectious diseases. Bacteriophages can become an efficient and sustainable alternative to antibiotics. But this is just a fraction of their potential. Embark on the journey with us! Unleash bacteriophage potential.
Something looks off?